Jon A. Read
Impact in
- Molecular Biology top 5%
- Cancer therapeutics and mechanisms
- Metabolism, Diabetes, and Cancer
- Biochemical and Molecular Research
- Protein Structure and Dynamics
- Toxicology top 5%
Papers in
-
- Cancer therapeutics and mechanisms 8
- Biochemical and Molecular Research 7
- Melanoma and MAPK Pathways 6
- Oncology 15
- Cytokine Signaling Pathways and Interactions 6
- Co-authors
- R.L. Brady (5 shared papers)Richard Barry Sessions (3 shared papers)V.J. Winter (1 shared paper)Rebecca Tranter (2 shared papers)David Carling (3 shared papers)Jason Breed (6 shared papers)Catherine Bardelle (5 shared papers)Dorin Toader (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (18 papers)Journal of Medicinal Chemistry (14 papers)Biochemical Journal (3 papers)ACS Chemical Biology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Jon A. Read
59 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 109
- Molecular Biology 1.9k
- Toxicology 73
- Cancer Research 286
- Organic Chemistry 556
- Computational Theory and Mathematics 318
Countries citing papers authored by Jon A. Read
This map shows the geographic impact of Jon A. Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon A. Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon A. Read more than expected).
Fields of papers citing papers by Jon A. Read
This network shows the impact of papers produced by Jon A. Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon A. Read. The network helps show where Jon A. Read may publish in the future.
Co-authors
The 25 scholars most cited alongside Jon A. Read, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 285 | |
| 2 | 2019 | 161 | |
| 3 | 2017 | 148 | |
| 4 | 2012 | 127 | |
| 5 | Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia. | 1995 | 126 |
| 6 | 2004 | 118 | |
| 7 | 2016 | 112 | |
| 8 | 2010 | 111 | |
| 9 | 2011 | 110 | |
| 10 | 1999 | 97 | |
| 11 | 2012 | 97 | |
| 12 | 2019 | 93 | |
| 13 | 2001 | 90 | |
| 14 | 2013 | 89 | |
| 15 | 2000 | 84 | |
| 16 | 2005 | 80 | |
| 17 | 2013 | 65 | |
| 18 | 2005 | 65 | |
| 19 | 2012 | 64 | |
| 20 | 2005 | 60 |
About Jon A. Read
Jon A. Read is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Genetics and Pathology and Forensic Medicine, having authored 59 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Biochemical and Molecular Research (7 papers), Tuberculosis Research and Epidemiology (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Cytokine Signaling Pathways and Interactions (6 papers), Cancer Mechanisms and Therapy (6 papers), Melanoma and MAPK Pathways (6 papers) and Pancreatic function and diabetes (4 papers). The work is most often cited by research in Molecular Biology (1.9k citations), Toxicology (73 citations), Cancer Research (286 citations), Organic Chemistry (556 citations) and Computational Theory and Mathematics (318 citations). Jon A. Read has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include R.L. Brady, Richard Barry Sessions, V.J. Winter, Rebecca Tranter, David Carling, Jason Breed, Catherine Bardelle, Dorin Toader, Huawei Chen and Jason G. Kettle. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Biochemical Journal, ACS Chemical Biology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.